Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.9M Buy
15,789
+1,841
+13% +$213K 0.17% 115
2025
Q4
$1.47M Buy
13,948
+7,856
+129% +$737K 0.14% 127
2025
Q3
$511K Buy
6,092
+2,347
+63% +$193K 0.11% 128
2025
Q2
$296K Buy
3,745
+199
+6% +$15.8K 0.07% 174
2025
Q1
$318K Buy
3,546
+17
+0.5% +$1.59K 0.09% 153
2024
Q4
$351K Buy
3,529
+247
+8% +$25.5K 0.1% 139
2024
Q3
$373K Sell
3,282
-180
-5% -$21.4K 0.11% 137
2024
Q2
$429K Buy
3,462
+1,483
+75% +$191K 0.14% 112
2024
Q1
$261K Buy
+1,979
New +$244K 0.09% 143
2023
Q2
$235K Sell
2,035
-214
-10% -$24.3K 0.07% 174
2023
Q1
$239K Buy
+2,249
New +$243K 0.08% 164

Other funds holding MRK

Sentinus LLC's MRK Position: Q1 2026 in Review

Sentinus LLC increased its Merck (MRK) stake by 13% in Q1 2026, buying an estimated $213K and bringing the position to 15,789 shares worth $1.9M. The position accounts for 0.17% of the portfolio, ranked #115.

Sentinus LLC first reported a position in MRK in Q1 2023 and has held it in 11 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Sentinus LLC held 15,789 shares of Merck worth $1.9M as of Q1 2026.
  • Sentinus LLC bought 1,841 Merck shares in Q1 2026, an estimated $213K.
  • Merck made up 0.17% of Sentinus LLC's portfolio in Q1 2026, its #115 holding.
  • Sentinus LLC first reported a position in Merck in Q1 2023 and has held it in 11 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Sentinus LLC's 13F filing for Q1 2026, filed 6 May 2026.